Detection of Activated Leukocyte Cell Adhesion Molecule in the Serum of Breast Cancer Patients and Implications for Prognosis

Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases

(2013) M. Ihnen et al.   DISEASE MARKERS

Activated Leukocyte Cell Adhesion Molecule Expression and Shedding in Thyroid Tumors

(2011) Francesca Miccichè et al.   PLoS One

Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial

(2010) Isabell Witzel et al.   BREAST CANCER RESEARCH AND TREATMENT

Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue

(2010) Sibyll Hein et al.   BREAST CANCER RESEARCH AND TREATMENT

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

(2010) M Ihnen et al.   BRITISH JOURNAL OF CANCER

CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction

(2010) P. Nair et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer

(2010) Xin Hong et al.   JOURNAL OF SURGICAL ONCOLOGY

Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer

(2009) Vathany Kulasingam et al.   INTERNATIONAL JOURNAL OF CANCER

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

(2008) M. Ihnen et al.   BREAST CANCER RESEARCH AND TREATMENT